Use of multikinase inhibitors/lenvatinib in singular thyroid cancer scenarios
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-10-01
|
| Series: | Cancer Medicine |
| Online Access: | https://doi.org/10.1002/cam4.5154 |